// App-Quantinova.ai

TCT-53 : Same-Day Discharge Post-Transcatheter Aortic Valve Replacement Using a Standardized Clinical Pathway During the COVID-19 Pandemic: The PROTECT TAVR Study

Researchers

Presenter

  • Madeleine Barker

Principal Investigators

  • Emily Perdoncin

  • Patricia Keegan

  • Chandan Devireddy

  • Kendra Grubb

  • Andrei Pop

  • Jeremiah Depta

  • Devesh Rai

  • Mark Spence

  • Jonathan Mailey

  • Douglas Muir

  • Mark Russo

  • Alexis Okoh

  • Meghan Smith

  • Masud Rana

  • Sandra Lauck

  • John Webb

  • David Wood

Medical Centers

  • Emory Healthcare, Atlanta, Georgia, USA

  • Royal Victoria Hospital, Belfast, Belfast, United Kingdom

  • Alexian Brothers Medical Center, Elk Grove Village, Illinois, USA

  • Sands-Constellation Heart Institute, Rochester General Hospital, Rochester, New York, USA

  • James Cook University Hospital, Middlesborough, United Kingdom

  • Robert Woods Johnson Medical School, New Brunswick, New Jersey, USA

  • Center for Cardiovascular Innovation, University of British Columbia, Vancouver, British Columbia, Canada

  • Rochester General Hospital, Rochester, New York, USA

  • NHS, Belfast, United Kingdom

  • Emory University Hospital Midtown, Atlanta, Georgia, USA

  • Emory University School of Medicine, Atlanta, Georgia, USA

  • Centre for Heart Valve Innovation, St. Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada

  • St Paul’s Hospital, Vancouver, British Columbia, Canada

Locations

  • United States

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Coronavirus disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved